PMA supplement
P190009 S006: OPRA Implant System, Abutment component
FDA PMA supplement · 135 Review Track For 30-Day Notice · Integrum AB
Key facts
| Original PMA | P190009 |
|---|---|
| Supplement number | S006 |
| Supplement type | 135 Review Track For 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | OPRA Implant System, Abutment component |
| Generic name | Osseoanchored prostheses for the rehabilitation of transfemoral amputees |
| Applicant | Integrum AB |
| Product code | PJY |
| Received date | Sep 27, 2024 |
| Decision date | Nov 20, 2025 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: